Kosunarty Fa is a Nephrology physician affiliated with Dallas Nephrology Associates. OpenAlex indexes 6 publications with 218 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1411 N Beckley Ave Ste 370
Dallas, TX 752031513
Telephone
214-358-2300Provider last certified this registry record 14 Nov 2023.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20259 payments
- Amgen Inc.Program year20259 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.2%Beta blocker13.5%Carvedilol83%Metoprolol Tartrate12%Metoprolol Succinate5%Part D<11 patientsCalcium channel blocker11.6%Nifedipine Er77%Amlodipine Besylate23%Part D≥65 patients+ 8 more classes in this area
Metabolism & gastrointestinal
27.9%Corticosteroid8.1%Prednisone100%Part D≥60 patientsSGLT2 inhibitor5.7%Farxiga61%Jardiance40%Part D≥16 patients+ 7 more classes in this area
Anti-infectives
10.9%Short-acting sulfonamides7.7%Sulfamethoxazole-Trimethoprim100%Part D≥55 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor2%Valganciclovir Hcl100%Part D≥24 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Use of Extracorporeal Kidney Replacement Therapy in the Management of Acute Iron Poisoning with Multiple Organ Failure
Journal of the American Society of Nephrology
2025 - Rare Case of Renal Vein Thrombosis in a Transplanted Kidney with Successful Endovascular Thrombectomy
Journal of the American Society of Nephrology
2023 - Outcome of Hepatitis C Virus-Infected Kidney Transplant Candidates Who Remain on the Waiting List
American Journal of Transplantation
2005 - Blood Pressure and the Survival of Renal Allografts from Living Donors
Journal of the American Society of Nephrology
2004 - Basiliximab plus low‐dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation
Clinical Transplantation
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Kim Rice, MD
Dallas Nephrology Associates
Richard Fuquay, MD
Dallas Nephrology Associates
Arun Chandrakantan, MD
Dallas Nephrology Associates
Cindy Corpier, MD
Dallas Nephrology Associates
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”